ImmunoAdvocate Perspectives: Navigating Cancer Immunotherapy and Survivorship August 15, 2024August 15, 2024 Max Mallet
Translating Science into Survival at the 8th Annual CICON Conference August 2, 2024August 22, 2024 Max Mallet
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma June 28, 2024October 29, 2024 Ajit Muley
Can a simple blood test tell you how your cancer therapy works? March 29, 2024March 29, 2024 Ajit Muley